VOLUME 3 (2012)
View Archive »
About The Cover
Figure 2 in Chow & Baker outlines a framework for translational research using genetically engineered mouse models (GEMMs) for high-grade astrocytoma (HGA).
|
|
Table of Contents
|
| Histone code human growth and cancer |
|
https://doi.org/10.18632/oncotarget.435
|
| 1-2 |
|
| Histone modification defects in developmental disorders and cancer |
|
https://doi.org/10.18632/oncotarget.436
|
| 3-4 |
|
| Epigenetic control of an oncogenic microRNA miR155 by BRCA1 |
|
https://doi.org/10.18632/oncotarget.433
|
| 5-6 |
|
| The Safety of Embryonic Stem Cell Therapy Relies on Teratoma Removal |
|
https://doi.org/10.18632/oncotarget.434
|
| 7-8 |
Reviews
|
| microRNA1/133a and microRNA206/133b clusters: Dysregulation and functional roles in human cancers |
|
https://doi.org/10.18632/oncotarget.424
|
| 9-21 |
Brief Reports
|
| Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells |
|
https://doi.org/10.18632/oncotarget.437
|
| 22-30 |
Research Papers
|
| A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIMdependent apoptosis in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.430
|
| 31-43 |
|
| Tumor suppressive microRNA1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.417
|
| 44-57 |
|
| “Picolog†a SyntheticallyAvailable Bryostatin Analog Inhibits Growth of MYCInduced Lymphoma In Vivo |
|
https://doi.org/10.18632/oncotarget.438
|
| 58-66 |
Research Perspectives
|
| Capturing the Molecular and Biological Diversity of HighGrade Astrocytoma in Genetically Engineered Mouse Models |
|
https://doi.org/10.18632/oncotarget.425
|
| 67-77 |
|
| Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.332
|
| 78-83 |
|
| Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics |
|
https://doi.org/10.18632/oncotarget.422
|
| 84-97 |
|
| Neoplastic cells are a rare component in human glioblastoma microvasculature |
|
https://doi.org/10.18632/oncotarget.427
|
| 98-106 |
|
| Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment |
|
https://doi.org/10.18632/oncotarget.439
|
| 107-111 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
